Primary Extracranial Meningioma Mimicking Musculoskeletal Malignancy: A Case Report

Seungju Han, Won Hee LeeThe Nerve 2022 · DOI

TL;DR

This case report describes a rare primary extracranial meningioma (PEM) that presented as a scalp mass with aggressive bone destruction, initially mimicking a malignant musculoskeletal tumor. Despite its "malignant" appearance on imaging, histological analysis revealed a benign WHO Grade I tumor that was successfully treated with surgical resection alone, remaining recurrence-free after four years.

What Problem Does This Paper Address?

Meningiomas are the most common primary brain tumors, typically arising from the meninges protecting the brain and spinal cord. However, primary extracranial meningiomas (PEMs)—those that develop entirely outside the neuraxis without any connection to intracranial structures—are exceedingly rare, accounting for only about 0.9% of all meningiomas.

The primary challenge addressed here is diagnostic mimicry. Because PEMs are so infrequent and can cause significant bone erosion (osteolysis) and muscle infiltration, they are often misidentified as aggressive malignancies like osteogenic sarcomas or myosarcomas. This paper aims to alert clinicians to PEM as a differential diagnosis for extracranial masses and reinforces the efficacy of surgical intervention over more aggressive adjuvant therapies for these specific cases.

Methods

The authors document the clinical journey of a 74-year-old female patient through several standard and specialized diagnostic and surgical steps:

  • Imaging: Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) were used to visualize the mass, bone thickening, and osteolysis.
  • Surgical Intervention: The team performed a gross total removal of the scalp tumor, including a craniectomy of the involved bone with a 1 cm tumor-free margin. The resulting skull defect was repaired using artificial bone cement (cranioplasty).
  • Histopathology & Immunohistochemistry (IHC): This is the "gold standard" for PEM diagnosis. The resected tissue was analyzed using:
  • H&E Staining: To identify classic meningothelial features like whorls and psammoma bodies.
  • EMA (Epithelial Membrane Antigen): A marker that shows intense positivity in meningiomas.
  • Ki-67: A protein used to measure the proliferation index (cell division rate); in this case, it was under 2%, confirming a slow-growing, benign (WHO Grade I) tumor.
  • Classification: The authors applied the Hoye classification system, which categorizes extracranial meningiomas based on their origin and connection to the cranium.

Datasets

As a clinical case report, this paper does not utilize a large-scale dataset or training benchmark. Instead, it contributes a high-quality clinical entry to the existing body of rare disease literature, referencing 15 previous studies to contextualize the patient's presentation within the Hoye classification framework.

Key Insights and Ideas

  • The "Great Pretender": The most striking insight is that a tumor can appear radiographically aggressive (destroying bone and invading muscle) while remaining histologically benign. This highlights the danger of relying solely on imaging for a prognosis.
  • Hoye Type C Classification: This case was identified as a "Type C" PEM—ectopic tumors with no connection to cranial nerves or intracranial structures. This is the rarest form of an already rare disease.
  • The Three Theories of Origin: The paper discusses why these tumors appear in strange places:
  • Misplaced Cells: Arachnoid cells may migrate abnormally during embryological development or through suture lines during head trauma.
  • Nerve Exit Points: They may arise from arachnoid cell clusters that "hitchhike" on cranial nerves as they exit the dura.
  • Mesenchymal Differentiation: Since meningiomas are mesenchymal in origin, multipotential mesenchymal cells already located outside the skull might simply differentiate into meningioma cells.
  • Surgical Priority: Because meningiomas are generally radioresistant, the paper emphasizes that complete surgical excision is the definitive treatment, often negating the need for chemotherapy or radiation.

Key Results

  • Final Diagnosis: The mass was confirmed as a WHO Grade I meningothelial meningioma.
  • Surgical Success: Gross total resection was achieved. Despite the initial suspicion of a high-grade malignancy (myosarcoma), the patient required no adjuvant radiation or chemotherapy.
  • Long-term Outcome: Follow-up imaging at 48 months (4 years) showed no evidence of tumor recurrence and no significant changes in the surrounding dural tissue.

Limitations and Future Work

The primary limitation is that this is a single-patient case report, which cannot be used to establish broad statistical trends. While the 48-month follow-up is robust, the rarity of PEM means that standardized treatment protocols are difficult to validate through large-scale clinical trials.

Future work in this area would likely involve molecular profiling of PEMs to see if they harbor the same genetic mutations (like NF2) as their intracranial counterparts, which could further clarify their developmental origins. The authors suggest that PEM should be consistently considered in the differential diagnosis of slow-growing head and neck tumors to avoid unnecessary or overly aggressive treatments.

Summary updated

Abstract

Primary extracranial meningioma (PEM) is a very rare disease that arises outside the dural covering of the brain or spinal cord. It is essentially an extracranial tumor and can mimic musculoskeletal malignancies. A 74-year-old woman presented with a mass on the right frontotemporal scalp that had been present for 2 years. Magnetic resonance imaging revealed osteolysis in the right frontal, temporal, and sphenoid bone and involvement of the right temporalis muscle, mimicking a musculoskeletal malignancy. The mass was resected, and the confirmed histological diagnosis was primary extracranial meningothelial meningioma (World Health Organization grade I). The patient was discharged without complications, and no evidence of tumor recurrence was apparent 48 months after surgery. This case supports complete surgical excision without adjuvant therapy as the modality of choice for PEM since meningioma is radioresistant and recurrence is very rare after adequate surgical resection.
BibTeX
@inproceedings{han2022primary,
  author = {Seungju Han and Won Hee Lee},
  title = {{Primary Extracranial Meningioma Mimicking Musculoskeletal Malignancy: A Case Report}},
  booktitle = {The Nerve},
  year = {2022},
  doi = {10.21129/nerve.2022.00108},
}
Figure